Sven Wehrwein, Director, on July 28, 2026, sold 25,000 shares in Atricure (ATRC) for $946,000. Following the Form 4 filing with the SEC, Wehrwein has control over a total of 40,518 common shares of the company, with 40,518 shares held directly.
SEC Filing: